Negro Roberto
Division of Endocrinology, "V. Fazzi" Hospital, Piazza F. Muratore, 73100 Lecce, Italy.
J Thyroid Res. 2014;2014:459791. doi: 10.1155/2014/459791. Epub 2014 Nov 4.
To determine an optimal time for follow-up of benign thyroid nodules, we retrospectively evaluated 249 euthyroid patients with uni-multinodular goiter, who underwent annual visit, and significant events that occurred in 5 years' time were registered. A significant event (appearance of new nodule, increase of nodule diameter >50%, appearance of compressive symptoms, thyroidectomy, repetition of FNA on the same nodule, and execution of FNA on new nodule) occurred in 26.1% of patients, with more than one event occurring in the same patient in 27.7% of cases. The majority of events (71.9%) were observed at 24- and 36-month follow-up visit. These results suggest that a patient diagnosed with benign nodular goiter may be safely followed-up at a 2-3-year interval time.
为确定甲状腺良性结节的最佳随访时间,我们回顾性评估了249例患有单发性或多发性甲状腺肿的甲状腺功能正常患者,这些患者每年接受一次随访,并记录了5年内发生的重大事件。26.1%的患者发生了重大事件(出现新结节、结节直径增大>50%、出现压迫症状、甲状腺切除术、对同一结节重复进行细针穿刺活检以及对新结节进行细针穿刺活检),27.7%的病例中同一患者发生了不止一次事件。大多数事件(71.9%)在24个月和36个月的随访中被观察到。这些结果表明,被诊断为良性结节性甲状腺肿的患者可以安全地每2至3年进行一次随访。